🌎 Plug Power Downgraded, Pool Initiated, PTC Therapeutics Downgraded and more…
RJ Hamster
Ratings changes for Plug Power, Pool, PTC Therapeutics, Roku, Exelixis, Chesapeake Energy, Nextracker and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe.
VIEW MY PORTFOLIO
December 19th, 2023
Buy this AI Stock Before Elon’s Announcement (ad)
Teeka Tiwari, the man who picked Nvidia before it skyrocketed as high as 5,246%, is now recommending this AI stock…
Because it’s most likely supplying Elon Musk with a key piece of advanced tech for his new AI venture.
Hurry… Elon Musk has promised that he “will share more information [about this AI project] over the next couple of weeks.”
Jeff Bezos Backs “Drug Smuggler” to Fight Alzheimer’s (ad)
A small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer’s, Parkinson’s and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>
CEO Mark Zuckerberg sold 28,009 shares of Meta Platforms stock in a transaction on Friday, December 15th. The stock was sold at an average price of $335.91, for a total value of $9,408,503.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $40.00 price target on the stock, up previously from $31.00. This represents a 34.4% upside from the current price of $29.77.
American International Group (NYSE:AIG) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $83.00 price target on the stock, up previously from $72.00. This represents a 23.1% upside from the current price of $67.44.
Amgen (NASDAQ:AMGN) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $326.00 price target on the stock, up previously from $286.00. This represents a 16.4% upside from the current price of $280.08.
Arvinas (NASDAQ:ARVN) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $63.00 price target on the stock, up previously from $25.00. This represents a 72.1% upside from the current price of $36.60.
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $20.00 price target on the stock, up previously from $15.00. This represents a 51.4% upside from the current price of $13.21.
Itron (NASDAQ:ITRI) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $91.00 price target on the stock, up previously from $72.00. This represents a 23.7% upside from the current price of $73.55.
Invivyd (NASDAQ:IVVD) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating. They now have a $4.00 price target on the stock, up previously from $1.00. This represents a 30.3% upside from the current price of $3.07.
Sunnova Energy International (NYSE:NOVA) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $26.00 price target on the stock, up previously from $13.00. This represents a 75.8% upside from the current price of $14.79.
Rockwell Automation (NYSE:ROK) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $357.00 price target on the stock, up previously from $280.00. This represents a 15.0% upside from the current price of $310.38.
Sunrun (NASDAQ:RUN) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $31.00 price target on the stock, up previously from $15.00. This represents a 62.7% upside from the current price of $19.05.
Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $55.00 price target on the stock, up previously from $29.00. This represents a 19.3% upside from the current price of $46.12.
Wave Life Sciences (NASDAQ:WVE) was upgraded by analysts at SVB Leerink LLC from a “market perform” rating to an “outperform” rating. They now have a $12.00 price target on the stock, up previously from $5.00. This represents a 138.1% upside from the current price of $5.04.
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (ad)
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Array Technologies (NASDAQ:ARRY) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $22.00 price target on the stock, down previously from $26.00. This represents a 21.0% upside from the current price of $18.18.
Banco de Chile (NYSE:BCH) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating.The current price is $23.04.
Banco Santander-Chile (NYSE:BSAC) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating.The current price is $19.65.
Masonite International (NYSE:DOOR) was downgraded by analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating. They now have a $92.00 price target on the stock, down previously from $106.00. This represents a 2.9% upside from the current price of $89.45.
Equinor ASA (NYSE:EQNR) was downgraded by analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating.The current price is $31.51.
Disc Medicine (NASDAQ:IRON) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $65.00 price target on the stock, up previously from $56.00. This represents a 12.0% upside from the current price of $58.05.
Kymera Therapeutics (NASDAQ:KYMR) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $26.00 price target on the stock. This represents a 3.6% upside from the current price of $25.09.
PureCycle Technologies (NYSE:PCT) was downgraded by analysts at Roth Mkm from a “buy” rating to a “neutral” rating. They now have a $3.00 price target on the stock, down previously from $6.00. This represents a 7.1% downside from the current price of $3.23.
PepsiCo (NASDAQ:PEP) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $176.00 price target on the stock, down previously from $185.00. This represents a 4.6% upside from the current price of $168.28.
Piper Sandler Companies (NYSE:PIPR) was downgraded by analysts at Northland Securities from an “outperform” rating to a “market perform” rating.The current price is $175.89.
Plug Power (NASDAQ:PLUG) was downgraded by analysts at Piper Sandler from a “neutral” rating to an “underweight” rating. They now have a $2.30 price target on the stock, down previously from $6.50. This represents a 48.2% downside from the current price of $4.44.
Prelude Therapeutics (NASDAQ:PRLD) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating. They now have a $4.00 price target on the stock, down previously from $10.00. This represents a 3.8% downside from the current price of $4.16.
PTC Therapeutics (NASDAQ:PTCT) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating. They now have a $28.00 price target on the stock. This represents a 0.4% upside from the current price of $27.90.
uniQure (NASDAQ:QURE) was downgraded by analysts at Mizuho from a “buy” rating to a “neutral” rating. They now have a $10.00 price target on the stock, down previously from $52.00. This represents a 47.9% upside from the current price of $6.76.
ScanSource (NASDAQ:SCSC) was downgraded by analysts at Northcoast Research from a “buy” rating to a “neutral” rating. They now have a $36.00 price target on the stock. This represents a 7.0% downside from the current price of $38.71.
SolarEdge Technologies (NASDAQ:SEDG) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $105.00 price target on the stock, down previously from $110.00. This represents a 6.4% upside from the current price of $98.64.
SiteOne Landscape Supply (NYSE:SITE) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $167.00 price target on the stock, up previously from $150.00. This represents a 2.0% upside from the current price of $163.77.
Vigil Neuroscience (NASDAQ:VIGL) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating. They now have a $4.00 price target on the stock, down previously from $13.00. This represents a 11.1% upside from the current price of $3.60.
Vertex Energy (NASDAQ:VTNR) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $4.00 price target on the stock, down previously from $6.00. This represents a 14.9% upside from the current price of $3.48.
Zurn Elkay Water Solutions (NYSE:ZWS) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $31.00 price target on the stock. This represents a 4.8% upside from the current price of $29.59.
Free Stock Analysis Report: See The True Value of Any Stock (ad)
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Arcellx (NASDAQ:ACLX) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $66.00 price target on the stock. This represents a 26.4% upside from the current price of $52.21.
BARK (NYSE:BARK) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $1.34 price target on the stock. This represents a 80.2% upside from the current price of $0.74.
Bruker (NASDAQ:BRKR) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $72.00 price target on the stock. This represents a 2.5% downside from the current price of $73.85.
Chewy (NYSE:CHWY) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $27.00 price target on the stock. This represents a 16.7% upside from the current price of $23.14.
Comstock Resources (NYSE:CRK) is now covered by analysts at Siebert Williams Shank. They set a “hold” rating and a $10.00 price target on the stock. This represents a 13.8% upside from the current price of $8.79.
Equifax (NYSE:EFX) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $273.00 price target on the stock. This represents a 9.3% upside from the current price of $249.71.
Elanco Animal Health (NYSE:ELAN) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $17.00 price target on the stock. This represents a 20.4% upside from the current price of $14.12.
Exelixis (NASDAQ:EXEL) is now covered by analysts at BTIG Research. They set a “buy” rating and a $27.00 price target on the stock. This represents a 14.0% upside from the current price of $23.69.
Freshpet (NASDAQ:FRPT) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $80.00 price target on the stock. This represents a 5.8% downside from the current price of $84.95.
Gulfport Energy (NASDAQ:GPOR) is now covered by analysts at Siebert Williams Shank. They set a “buy” rating and a $200.00 price target on the stock. This represents a 51.6% upside from the current price of $131.96.
Hillenbrand (NYSE:HI) is now covered by analysts at CL King. They set a “strong-buy” rating and a $61.00 price target on the stock. This represents a 33.8% upside from the current price of $45.58.
Immunome (NASDAQ:IMNM) is now covered by analysts at Wedbush. They set an “outperform” rating and a $12.00 price target on the stock. This represents a 49.4% upside from the current price of $8.03.
Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Scotiabank. They set a “sector perform” rating on the stock.The current price is $62.50.
MoneyLion (NYSE:ML) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $75.00 price target on the stock. This represents a 39.2% upside from the current price of $53.87.
Myriad Genetics (NASDAQ:MYGN) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $20.00 price target on the stock. This represents a 4.6% downside from the current price of $20.96.
New Fortress Energy (NASDAQ:NFE) is now covered by analysts at Capital One Financial Co.. They set an “equal weight” rating on the stock.The current price is $36.92.
Nextracker (NASDAQ:NXT) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $60.00 price target on the stock. This represents a 30.7% upside from the current price of $45.92.
PetIQ (NASDAQ:PETQ) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $22.00 price target on the stock. This represents a 17.0% upside from the current price of $18.80.
Pool (NASDAQ:POOL) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $400.00 price target on the stock. This represents a 1.8% upside from the current price of $392.79.
Patterson-UTI Energy (NASDAQ:PTEN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $12.00 price target on the stock. This represents a 6.7% upside from the current price of $11.25.
Qiagen (NYSE:QGEN) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $44.00 price target on the stock. This represents a 3.1% upside from the current price of $42.67.
REE Automotive (NASDAQ:REE) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $15.00 price target on the stock. This represents a 197.0% upside from the current price of $5.05.
Revvity (NYSE:RVTY) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $95.00 price target on the stock. This represents a 8.9% downside from the current price of $104.29.
Synovus Financial (NYSE:SNV) is now covered by analysts at Stephens. They set an “equal weight” rating and a $40.00 price target on the stock. This represents a 3.1% upside from the current price of $38.79.
SouthState (NASDAQ:SSB) is now covered by analysts at Stephens. They set an “equal weight” rating and a $78.00 price target on the stock. This represents a 10.6% downside from the current price of $87.24.
TransUnion (NYSE:TRU) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $81.00 price target on the stock. This represents a 16.3% upside from the current price of $69.63.
Petco Health and Wellness (NASDAQ:WOOF) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $3.11 price target on the stock. This represents a 5.1% upside from the current price of $2.96.
Yum China (NYSE:YUMC) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $58.00 price target on the stock. This represents a 41.7% upside from the current price of $40.94.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat’s free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
